Glen Harbor Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$657K Hold
6,834
0.01% 609
2019
Q2
$585K Hold
6,834
0.01% 655
2019
Q1
$569K Hold
6,834
0.01% 627
2018
Q4
$439K Hold
6,834
0.01% 668
2018
Q3
$541K Buy
6,834
+1,666
+32% +$129K 0.01% 686
2018
Q2
$378K Hold
5,168
0.01% 744
2018
Q1
$327K Hold
5,168
0.01% 798
2017
Q4
$263K Buy
5,168
+918
+22% +$47.8K 0.01% 884
2017
Q3
$223K Buy
4,250
+680
+19% +$34.1K 0.01% 868
2017
Q2
$182K Buy
3,570
+1,768
+98% +$87.5K ﹤0.01% 884
2017
Q1
$80K Sell
1,802
-374
-17% -$16.1K ﹤0.01% 1008
2016
Q4
$96K Buy
+2,176
New +$92.5K ﹤0.01% 911

Other funds holding CNMD

Glen Harbor Capital Management's CNMD Position: Q3 2019 in Review

Glen Harbor Capital Management held its CONMED (CNMD) position steady in Q3 2019 at 6,834 shares worth $657K. The position accounts for 0.01% of the portfolio, ranked #609.

Glen Harbor Capital Management first reported a position in CNMD in Q4 2016 and has held it in 12 quarters since. 234 funds tracked by Wall St. Rank hold CNMD as of Q3 2019.

  • Glen Harbor Capital Management held 6,834 shares of CONMED worth $657K as of Q3 2019.
  • Glen Harbor Capital Management left its CONMED share count unchanged in Q3 2019.
  • CONMED made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #609 holding.
  • Glen Harbor Capital Management first reported a position in CONMED in Q4 2016 and has held it in 12 quarters since.
  • 234 funds tracked by Wall St. Rank held CONMED as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.